Genetic variations in CCK2 receptor in PVG hooded and Sprague-Dawley rats and its mRNA expression on cat exposure

Behavioral Neuroscience

Volumn 117, Issue 2, 2003, Pages 385-390

  Wang, H ^a   Zhu, Y Z ^a   Farook, J M ^a   Moochhala, S ^b   Teo, A L ^b   Lee, L K H ^b   Wong, P T H ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Defense Medical Research Institute   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ RECEPTOR; MESSENGER RNA; 2 (2 (5 BROMO 1H INDOL 3 YL)ETHYL) 3 (1 METHYLETHOXYPHENYL) 4 (3H) QUINAZOLINONE; 2-(2-(5-BROMO-1H-INDOL-3-YL)ETHYL)-3-(1-METHYLETHOXYPHENYL)-4-(3H)-QUINAZOLINONE; CHOLECYSTOKININ B RECEPTOR; QUINAZOLINE DERIVATIVE; QUINAZOLINONE DERIVATIVE; TETRAGASTRIN;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CAT; CONTROLLED STUDY; GENETIC VARIABILITY; IMMOBILIZATION; NONHUMAN; PREDATOR; PROTEIN EXPRESSION; RAT; RAT STRAIN; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; ANIMAL BEHAVIOR; BIOSYNTHESIS; BRAIN; COMPARATIVE STUDY; DNA SEQUENCE; DRUG ANTAGONISM; DRUG EFFECT; EXON; FEAR; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; INTRON; MALE; METHODOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CATS; EXONS; FEAR; GENE EXPRESSION REGULATION; INTRONS; MALE; QUINAZOLINES; QUINAZOLINONES; RATS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; TETRAGASTRIN; VARIATION (GENETICS);

EID: 0037381578     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.117.2.385     Document Type: Article

References (31)

1. Adamec, R. E., Shallow, T., & Budgell, J. (1997). Blockade of CCK(B), but not CCK(A), receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: Implications for anxiety associated with posttraumatic stress disorder. Behavioral Neuroscience, 111, 435-449.
2. Beinborn, M., Lee, Y. M., McBride, E. W., Quinn, S. M., & Kopin, A. S. (1993, March 25). A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature, 362, 348-350.
3. Bert, B., Fink, H., Sohr, R., & Rex, A. (2001). Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety. Pharmacology Biochemistry and Behavior, 70, 411-420.
4. Blanchard, D. C., Weatherspoon, A., Shepherd, J., Rodgers, R. J., Weiss, S. M., & Blanchard, R. J. (1991). "Paradoxical" effects of morphine on antipredator defense reactions in wild and laboratory rats. Pharmacology Biochemistry and Behavior, 40, 819-828.
5. Bradwejn, J., Koszychi, D., Couetoux du Tertre, A., Bourin, M., Palmour, R., & Ervin, F. (1992). The cholecystokinin hypothesis of panic and anxiety disorders: A review. Journal of Psychopharmacology, 6, 345-351.
6. Di Paola, R., Frittitta, L., Miscio, G., Bozzali, M., Baratta, R., Centra, M., et al. (2002). A variation in 3′ UTR of PTP1B increases specific gene expression and associates with insulin resistance. American Journal of Human Genetics, 70, 806-812.
7. Farook, J. M., Zhu, Y. Z., Wang, H., Moochhala, S., Lee, L., & Wong, P. T.-H. (2001). Strain differences in freezing behavior of PVG hooded and Sprague-Dawley rats: Differential cortical expression of cholecystokinin2 receptors. NeuroReport, 12, 2717-2720.
8. Greco, A., Simonin, D., Diaz, J. J., Barjhoux, L., Kindbeiter, K., Madjar, J. J., & Masse, T. (1994) The DNA sequence coding for the 5′ untranslated region of herpes simplex virus type 1 ICP22 mRNA mediates a high level of gene expression. Journal of General Virology, 75, 1693-1702.
9. Griebel, G., Perrault, G., & Sanger, D. J. (1997). CCK receptor antagonists in animal models of anxiety: Comparison between exploration tests, conflict procedures and a model based on defensive behaviours. Behavioural Pharmacology, 8, 549-560.
10. Hormuzdi, S. G., Penttinen, R., Jaenisch, R., & Bornstein, P. (1998). A gene-targeting approach identifies a function for the first intron in expression of the alphal(I) collagen gene. Molecular and Cellular Biology, 18, 3368-3375.
11. Izumi, T., Inoue, T., Tsuchiya, K., Hashimoto, S., Ohmori, T., & Koyama, T. (1996). Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats. European Journal of Pharmacology, 300, 25-31.
12. Kennedy, J. L., Bradwejn, J., Koszycki, D., King, N., Crowe, R., Vincent, J., & Fourie, O. (1999). Investigation of cholecystokinin system genes in panic disorder. Molecular Psychiatry, 4, 284-285.
13. Kopin, A. S., McBride, E. W., Gordon, M. C., Quinn, S. M., & Beinborn, M. (1997). Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy. Proceedings of the National Academy of Sciences, USA, 94, 11043-11048.
14. Lines, C., Challenor J., & Traub, M. (1995). Cholecystokinin and anxiety in normal volunteers: An investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260. British Journal of Clinical Pharmacology, 39, 235-242.
15. Matto, V., Harro, J., & Allikmets, L. (1996). The effects of cholecystokinin A and B receptor antagonists, devazepide and L 365260, on citalopraminduced decrease of exploratory behaviour in rat. Journal of Physiology and Pharmacology, 47, 661-669.
16. National Center for Biotechnology Information. (2002). R.norvegicus cckb . . . [gi:558236]. Retrieved March 2001, from http://www.ncbi.nlm.nih .gov/entrez/
17. Noble, F., & Roques, B. P. (1999). CCK-B receptor: Chemistry, molecular biology, biochemistry and pharmacology. Progress in Neurobiology, 58, 349-379.
18. Okubo, T., & Harada, S. (2001). Polymorphisms of the CCK, CCK-AR and CCK-BR genes: An association with alcoholism study. Journal of Alcohol Studies, 62, 413-421.
19. Revel, L., Mennuni, L., Garofalo, P., & Makovec, F. (1998). CR 2945: A novel CCK-B receptor antagonist with anxiolytic-like activity. Behavioaral Pharmacology, 9, 183-194.
20. Rex, A., Barth, T., Voigt, J. P., Domeney, A. M., & Fink, H. (1994). Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Neuroscience Letters, 172, 139-142.
21. Rex, A., Sondern, U., Voigt, J. P., Franck, S., & Fink, H. (1996). Strain differences in fear-motivated behavior of rats. Pharmacology Biochemistry and Behavior, 54, 107-111.
22. Schmitt, U., & Hiemke, C. (1998). Strain differences in open-field and elevated plus-maze behavior of rats without and with pretest handling. Pharmacology Biochemistry and Behavior, 59, 807-811.
23. Singh, L., Lewis, A. S., Field, M. J., Hughes, J., & Woodruff, G. N. (1991). Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proceedings of the National Academy of Sciences, USA, 88, 1130-1133.
24. Tachikawa, H., Harada, S., Kawanishi, Y., Okubo, T., & Shiraishi, H. (1999). Novel polymorphism in the promoter and coding regions of the human cholecystokinin B receptor gene: An association analysis with schizophrenia. American Journal of Medical Genetics, 88, 700-704.
25. Tsutsumi, T., Akiyoshi, J., Hikichi, T., Kiyota, A., Kohno, Y., Katsuragi, S., et al. (2001). Suppression of conditioned fear by administration of CCKB receptor antisense oligodeoxynucleotide into the lateral ventricle. Pharmacopsychiatry, 34, 232-237.
26. Vanakoski, J., Virkkunen., M., Naukkarinen, H., & Goldman, D. (2001). No association of CCK and CCKB receptor polymorphisms with alcohol dependence. Psychiatric Research, 102, 1-7.
27. van Gaalen, M. M., & Steckler, T. (2000). Behavioural analysis of four mouse strains in an anxiety test battery. Behavioural Brain Research, 115, 95-106.
28. van Megen, H. J., Weatenberg, H. G. M., den Boer, J. A., & Kahn, R. S. (1996). Cholecystokinin in anxiety. European Journal of Neuropsychopharmacology, 6, 263-280.
29. Voikar, V., Koks, S., Vasar, E., & Rauvala, H. (2001). Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiology & Behavior, 72, 271-281.
30. Woodruff, G. N., Hill, D. R., Boden, P., Pinnock, R., Singh, L., & Hughes, J. (1991). Functional role of brain CCK receptors. Neuropeptides, 19(Suppl), 45-56.
31. Zhu, Y. Z., Chimon, G. N., Zhu, Y. C., Lu, Q., Li, B., Hu, H. Z., et al. (2000). Expression of angiotensin II AT2 receptor in the acute phase of stroke in rats. NeuroReport, 11, 1191-1194.